{"id":"metronidazole-bq10","safety":{"commonSideEffects":[{"rate":"10-20","effect":"Metallic taste"},{"rate":"10-15","effect":"Nausea"},{"rate":"5-10","effect":"Headache"},{"rate":"1-2","effect":"Peripheral neuropathy"},{"rate":null,"effect":"Disulfiram-like reaction with alcohol"},{"rate":"5-10","effect":"Darkened urine"}]},"_chembl":{"chemblId":"CHEMBL137","moleculeType":"Small molecule","molecularWeight":"171.16"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"The drug is activated by anaerobic organisms' electron transport systems, which reduce the nitro group to form reactive intermediates that damage DNA and inhibit nucleic acid synthesis. This mechanism makes it effective against anaerobic bacteria and certain parasites while having minimal activity against aerobic organisms. It is bactericidal and antiprotozoal in action.","oneSentence":"Metronidazole is a nitroimidazole antibiotic that disrupts bacterial and parasitic DNA by generating reactive free radicals after being reduced in anaerobic environments.","_ai_confidence":"high"},"_scrapedAt":"2026-03-27T23:54:59.319Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Anaerobic bacterial infections"},{"name":"Trichomoniasis"},{"name":"Amebiasis"},{"name":"Giardiasis"},{"name":"Clostridioides difficile infection"},{"name":"Bacterial vaginosis"}]},"trialDetails":[{"nctId":"NCT03208426","phase":"PHASE4","title":"Sequential Versus Quadruple Therapy in the Second-line Treatment","status":"UNKNOWN","sponsor":"National Taiwan University Hospital","startDate":"2017-10-01","conditions":"Helicobacter Pylori Infection","enrollment":240}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":2,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Flagyl"],"phase":"marketed","status":"active","brandName":"Metronidazole (BQ10)","genericName":"Metronidazole (BQ10)","companyName":"National Taiwan University Hospital","companyId":"national-taiwan-university-hospital","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Metronidazole is a nitroimidazole antibiotic that disrupts bacterial and parasitic DNA by generating reactive free radicals after being reduced in anaerobic environments. Used for Anaerobic bacterial infections, Trichomoniasis, Amebiasis.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}